Zydena is under approval process in China

Published: 2006-12-05 06:57:00

Updated: 2006-12-05 06:57:00

Dong-A PharmTech Co., Ltd. is an affiliate of Dong-A Pharmaceutical Co. Ltd., said it initiated the approval process for Zydena, its new erectile dysfunction drug, in China by filing for import verification.

The company is expecting to complete the requirements of the Chinese drug regulatory a...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK